foxo4-dri senolytic peptide foxo4-dri FOXO4-DRI - Beverly Hills Rejuvenation
FOXO4 DRI Beverly Hills Rejuvenation Center Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress FOXO4 DRI Dosing: 1mg Senolytic Protocol (2026)
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





